TY - JOUR
T1 - The three-dimensional structures of tick carboxypeptidase inhibitor in complex with A/B carboxypeptidases reveal a novel double-headed binding mode
AU - Arolas, Joan L.
AU - Popowicz, Grzegorz M.
AU - Lorenzo, Julia
AU - Sommerhoff, Christian P.
AU - Huber, Robert
AU - Aviles, Francesc X.
AU - Holak, Tad A.
PY - 2005/7/15
Y1 - 2005/7/15
N2 - The tick carboxypeptidase inhibitor (TCI) is a proteinaceous inhibitor of metallo-carboxypeptidases present in the blood-sucking tick Rhipicephalus bursa. The three-dimensional crystal structures of recombinant TCI bound to bovine carboxypeptidase A and to human carboxypeptidase B have been determined and refined at 1.7 Å and at 2.0 Å resolution, respectively. TCI consists of two domains that are structurally similar despite the low degree of sequence homology. The domains, each consisting of a short α-helix followed by a small twisted antiparallel β-sheet, show a high level of structural homology to proteins of the β-defensin-fold family. TCI anchors to the surface of mammalian carboxypeptidases in a double-headed manner not previously seen for carboxypeptidase inhibitors: the last three carboxy-terminal amino acid residues interact with the active site of the enzyme in a way that mimics substrate binding, and the N-terminal domain binds to an exosite distinct from the active-site groove. The structures of these complexes should prove valuable in the applications of TCI as a thrombolytic drug and as a basis for the design of novel bivalent carboxypeptidase inhibitors. © 2005 Elsevier Ltd. All rights reserved.
AB - The tick carboxypeptidase inhibitor (TCI) is a proteinaceous inhibitor of metallo-carboxypeptidases present in the blood-sucking tick Rhipicephalus bursa. The three-dimensional crystal structures of recombinant TCI bound to bovine carboxypeptidase A and to human carboxypeptidase B have been determined and refined at 1.7 Å and at 2.0 Å resolution, respectively. TCI consists of two domains that are structurally similar despite the low degree of sequence homology. The domains, each consisting of a short α-helix followed by a small twisted antiparallel β-sheet, show a high level of structural homology to proteins of the β-defensin-fold family. TCI anchors to the surface of mammalian carboxypeptidases in a double-headed manner not previously seen for carboxypeptidase inhibitors: the last three carboxy-terminal amino acid residues interact with the active site of the enzyme in a way that mimics substrate binding, and the N-terminal domain binds to an exosite distinct from the active-site groove. The structures of these complexes should prove valuable in the applications of TCI as a thrombolytic drug and as a basis for the design of novel bivalent carboxypeptidase inhibitors. © 2005 Elsevier Ltd. All rights reserved.
KW - Carboxypeptidase inhibitor
KW - Crystal structure
KW - Inhibitor-enzyme complex
KW - Metallo-carboxypeptidase
KW - Pro-fibrinolytic drug
U2 - https://doi.org/10.1016/j.jmb.2005.05.015
DO - https://doi.org/10.1016/j.jmb.2005.05.015
M3 - Article
SN - 0022-2836
VL - 350
SP - 489
EP - 498
JO - Journal of Molecular Biology
JF - Journal of Molecular Biology
ER -